Before suspension there was only 4000 shares available for sale. And was sold down on very very small volume indicating 99% of holders were not selling only the very short termers and day traders.
There was a buyer for 1% of the company 20000 shares largest bid I've personally seen on mdc buy side. No one sold into it. Another bidder came in front of them buyer for 5000 shares. Only small amount sold into it. Then day later TH.
Its not like there was a rush to exit.
CAN has managed to get in debt of 70 million$ with no prospects. MDC no debt. Nanocelle has been seriously verified for its effectiveness efficacious and tolerable for quite a while.
Shaun Hall mentions on several recent (within 18 months) interviews interest from top pharma.
Most recent announcement mentions significant international interest.
Since IPO MDC has been on track and target for verifying Nanabis as an effective chronic pain treatment in replace of opioid especially in cancer bone pain. Also recently Nanocelle suggested in replacement of needle vaccines, insulin etc.
With the amount of boxes continually ticked since IPO and progression towards an FDA approved drug in replacement of Opioids surely there is some value for Nancolle as a whole and new drug delivery method
Google Nanocele and medlab is at the top and own it patented until 2036.
Surely more to this than meets the eye. Considering the mess all other cannabis related stocks are in. Medlab imo has gone about the research and drug progression better than all the rest.
Add to My Watchlist
What is My Watchlist?